middle.news
Bellberry Approval Unlocks New Sites for Racura’s HARNESS-1 Lung Cancer Trial
8:46am on Friday 3rd of July, 2026 AEST
•
Healthcare
Read Story
Bellberry Approval Unlocks New Sites for Racura’s HARNESS-1 Lung Cancer Trial
8:46am on Friday 3rd of July, 2026 AEST
Key Points
Bellberry HREC approval expands HARNESS-1 trial sites
Chris O’Brien Lifehouse and Austin Health to activate soon
Trial tests RC220 with osimertinib in EGFR-mutant NSCLC
Dose escalation and randomised expansion phases planned
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Racura Oncology (ASX:RAC)
OPEN ARTICLE